| J9271 | Injection, pembrolizumab, 1 mg | 27,200 | $40 | $1.2M |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 800 | $90 | $74.6K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 34,000 | $1 | $68K |
| J0897 | Injection, denosumab, 1 mg | 3,420 | $20 | $65K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 640 | $100 | $64.2K |
| Q5122 | Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg | 650 | $90 | $57.7K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 520 | $80 | $41.3K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 490 | $60 | $29.6K |
| 88185 | The lab analyst performs the technical component of a flow cytometry procedure using cell surface, cytoplasmic, or nuclear markers to characterize cells and aid clinicians in diagnosing patients with… | 1,120 | $20 | $20.2K |
| 99232 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 320 | $60 | $19.5K |